Michiel C.T. van Zeijl
Leiden University Medical Center(NL)Dutch Institute for Clinical Auditing(NL)
Publications by Year
Research Areas
CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, Cutaneous Melanoma Detection and Management, Melanoma and MAPK Pathways, Immunotherapy and Immune Responses
Most-Cited Works
- → Intestinal Vaginoplasty Revisited: A Review of Surgical Techniques, Complications, and Sexual Function(2014)180 cited
- → Association of Anti-TNF with Decreased Survival in Steroid Refractory Ipilimumab and Anti-PD1–Treated Patients in the Dutch Melanoma Treatment Registry(2020)177 cited
- → Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune Disease(2021)104 cited
- → (Neo)adjuvant systemic therapy for melanoma(2016)61 cited
- → Switching to Immune Checkpoint Inhibitors upon Response to Targeted Therapy; The Road to Long-Term Survival in Advanced Melanoma Patients with Highly Elevated Serum LDH?(2019)42 cited
- → Real‐world outcomes of advanced melanoma patients not represented in phase III trials(2020)36 cited
- → Metastatic Uveal Melanoma: Treatment Strategies and Survival—Results from the Dutch Melanoma Treatment Registry(2019)31 cited
- → Vemurafenib in BRAF-mutant metastatic melanoma patients in real-world clinical practice: prognostic factors associated with clinical outcomes(2018)30 cited
- → Survival outcomes of patients with advanced melanoma from 2013 to 2017: Results of a nationwide population-based registry(2020)29 cited
- → Long-term survival of patients with advanced melanoma treated with BRAF-MEK inhibitors(2022)26 cited